ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
NCT00077246
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
paclitaxel albumin-stabilized nanoparticle formulation
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]